Publications by authors named "E Vilarrasa-Rull"

Claim this Profile
R
Real-World Experience With Secukinumab for Hidradenitis Suppurativa: A Multicenter Retrospective Analysis of 263 Patients From the SECU-SPAIN Study.
A Martorell-Calatayud, E Vilarrasa-Rull, P Fernandez-Crehuet, A Molina-Leyva, M Mansilla

Actas Dermosifiliogr· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Polymorphisms in Psoriasis: Investigating Genetic Variations for Precise Profiling of Response to Brodalumab in Real-Life Clinical Practice.
B Butrón-Bris, M Llamas-Velasco, S Armesto, A Sahuquillo-Torralba, J Pujol-Montcusí, E Vilarrasa-Rull

Actas Dermosifiliogr· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real-Life Cohort and Literature Review.
Ofelia Baniandrés, Inmaculada Balaguer Franch, Eva Vilarrasa Rull, Adrián Imbernón Moya, María Luisa Alonso Pacheco

Int J Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Translated article] Measurement Assessment of Minimal Disease Activity in Psoriasis in Spain: A National Cross-Sectional Study.
G Carretero Hernández, M Ara Martín, S Armesto Alonso, I Belinchón Romero, N Eiris Salvado

Actas Dermosifiliogr· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice.
B Butrón-Bris, M Llamas-Velasco, M C Ovejero-Benito, J Santos-Juanes, A Martínez-López, E Vilarrasa-Rull

Exp Dermatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis